These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


451 related items for PubMed ID: 34806156

  • 1. microRNA-15b-5p shuttled by mesenchymal stem cell-derived extracellular vesicles protects podocytes from diabetic nephropathy via downregulation of VEGF/PDK4 axis.
    Zhao T, Jin Q, Kong L, Zhang D, Teng Y, Lin L, Yao X, Jin Y, Li M.
    J Bioenerg Biomembr; 2022 Feb; 54(1):17-30. PubMed ID: 34806156
    [Abstract] [Full Text] [Related]

  • 2. Adipose mesenchymal stem cell-derived extracellular vesicles containing microRNA-26a-5p target TLR4 and protect against diabetic nephropathy.
    Duan Y, Luo Q, Wang Y, Ma Y, Chen F, Zhu X, Shi J.
    J Biol Chem; 2020 Sep 11; 295(37):12868-12884. PubMed ID: 32580945
    [Abstract] [Full Text] [Related]

  • 3. MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20.
    Ding X, Jing N, Shen A, Guo F, Song Y, Pan M, Ma X, Zhao L, Zhang H, Wu L, Qin G, Zhao Y.
    J Endocrinol Invest; 2021 Jun 11; 44(6):1175-1184. PubMed ID: 32930981
    [Abstract] [Full Text] [Related]

  • 4. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
    Gao J, Liang Z, Zhao F, Liu X, Ma N.
    Bioengineered; 2022 May 11; 13(5):12275-12288. PubMed ID: 35603354
    [Abstract] [Full Text] [Related]

  • 5. Exosomal microRNA-16-5p from human urine-derived stem cells ameliorates diabetic nephropathy through protection of podocyte.
    Duan YR, Chen BP, Chen F, Yang SX, Zhu CY, Ma YL, Li Y, Shi J.
    J Cell Mol Med; 2021 Dec 11; 25(23):10798-10813. PubMed ID: 31568645
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
    Zhang SZ, Qiu XJ, Dong SS, Zhou LN, Zhu Y, Wang MD, Jin LW.
    Eur Rev Med Pharmacol Sci; 2019 Feb 11; 23(3):1248-1256. PubMed ID: 30779094
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hsa_circ_0037128 aggravates high glucose-induced podocytes injury in diabetic nephropathy through mediating miR-31-5p/KLF9.
    Fang R, Cao X, Zhu Y, Chen Q.
    Autoimmunity; 2022 Jun 11; 55(4):254-263. PubMed ID: 35285770
    [Abstract] [Full Text] [Related]

  • 9. A NOVEL CIRC_SUPT3/MIR-185-5P/G3BP2 CERNA NETWORK REGULATES HIGH GLUCOSE-INDUCED INJURY IN MOUSE PODOCYTE MPC5 CELLS.
    Li Y, Wang W, Liu N, Wang K, Ren F.
    Shock; 2024 Aug 01; 62(2):227-234. PubMed ID: 38813926
    [Abstract] [Full Text] [Related]

  • 10. High Glucose Induces Mesangial Cell Apoptosis through miR-15b-5p and Promotes Diabetic Nephropathy by Extracellular Vesicle Delivery.
    Tsai YC, Kuo MC, Hung WW, Wu LY, Wu PH, Chang WA, Kuo PL, Hsu YL.
    Mol Ther; 2020 Mar 04; 28(3):963-974. PubMed ID: 31991106
    [Abstract] [Full Text] [Related]

  • 11. MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3.
    Wang L, Li H.
    Biosci Rep; 2020 Apr 30; 40(4):. PubMed ID: 32309847
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of lncRNA-PAX8-AS1-N directly associated with VEGF/TGF-β1/8-OhdG enhances podocyte apoptosis in diabetic nephropathy.
    Shen Y, Tong ZW, Zhou Y, Sun Y, Xie Y, Li R, Liu H.
    Eur Rev Med Pharmacol Sci; 2020 Jun 30; 24(12):6864-6872. PubMed ID: 32633379
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. microRNA-15b-5p encapsulated by M2 macrophage-derived extracellular vesicles promotes gastric cancer metastasis by targeting BRMS1 and suppressing DAPK1 transcription.
    Cao Y, Tu Y, Xiong J, Tan S, Luo L, Wu A, Shu X, Jie Z, Li Z.
    J Exp Clin Cancer Res; 2022 Apr 22; 41(1):152. PubMed ID: 35449111
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-15b shuttled by bone marrow mesenchymal stem cell-derived extracellular vesicles binds to WWP1 and promotes osteogenic differentiation.
    Li Y, Wang J, Ma Y, Du W, Feng H, Feng K, Li G, Wang S.
    Arthritis Res Ther; 2020 Nov 16; 22(1):269. PubMed ID: 33198785
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-770-5p contributes to podocyte injury via targeting E2F3 in diabetic nephropathy.
    Guo J, Han J, Liu J, Wang S.
    Braz J Med Biol Res; 2020 Nov 16; 53(9):e9360. PubMed ID: 32696822
    [Abstract] [Full Text] [Related]

  • 17. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis.
    Du Z, Wu T, Liu L, Luo B, Wei C.
    J Cell Mol Med; 2021 Jan 16; 25(2):701-715. PubMed ID: 33342075
    [Abstract] [Full Text] [Related]

  • 18. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte.
    Jin J, Shi Y, Gong J, Zhao L, Li Y, He Q, Huang H.
    Stem Cell Res Ther; 2019 Mar 15; 10(1):95. PubMed ID: 30876481
    [Abstract] [Full Text] [Related]

  • 19. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells relieves diabetic retinopathy through a microRNA-30c-5p-dependent mechanism.
    He Y, Zhang Z, Yao T, Huang L, Gan J, Lv H, Chen J.
    Diabetes Res Clin Pract; 2022 Aug 15; 190():109861. PubMed ID: 35367521
    [Abstract] [Full Text] [Related]

  • 20. Delivery of miR-15b-5p via magnetic nanoparticle-enhanced bone marrow mesenchymal stem cell-derived extracellular vesicles mitigates diabetic osteoporosis by targeting GFAP.
    Xu C, Wang Z, Liu Y, Duan K, Guan J.
    Cell Biol Toxicol; 2024 Jul 05; 40(1):52. PubMed ID: 38967699
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.